EIF4E3 is an immune infiltration correlated prognosticator in colon cancer

YQ. Guo, YZ. Jiang, CH. Chen, LJ. Wu, HJ , KS. Chen, JJ. Xia, ZY. Liu

Article ID: 4459
Vol 35, Issue 5, 2021
DOI: https://doi.org/10.54517/jbrha4459
Received: 8 November 2021; Accepted: 8 November 2021; Available online: 8 November 2021; Issue release: 8 November 2021

Abstract

Colon cancer is a highly malignant gastrointestinal cancer, and genes in the tumor infiltrating cells and microenvironment are emerging as pivotal players in its development and prognosis. In this study, TIMER and StarBase tools were used to find whether EIF4E3 gene was downregulated in colon tissues, and whether lower expression of EIF4E3 was associated with poor prognosis in colon cancer patients, as well as to ascertain that EIF4E3 could regulate immune-related pathways by gene set enrichment analysis (GSEA). Using TIMER (Tumor Immune Estimation Resource) database and ImmuneCellAI tools, it was found that EIF4E3 expression was correlated with tumor immune infiltrates in colon cancer. The results identified EIF4E3 as an immune infiltrate-correlated prognosticator in colon cancer.


Keywords

EIF4E3;immune infiltration;prognosticator;colon cancer;Th17 cells


References

Supporting Agencies



Copyright (c) 2021 YQ. Guo, YZ. Jiang, CH. Chen, LJ. Wu, HJ, KS. Chen, JJ. Xia, ZY. Liu




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).